LSA
TAK icon

Leonteq Securities AG’s Takeda Pharmaceutical TAK Stock Holding History

Leonteq Securities AG’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-8,000
Closed -$104K – 1354
2022
Q3 		$104K Hold
8,000
– – ﹤0.01% 635
2022
Q2 		$112K Hold
8,000
– – ﹤0.01% 660
2022
Q1 		$115K Sell
8,000
-3,780
-32% -$55.5K ﹤0.01% 704
2021
Q4 		$161K Buy
11,780
+8,000
+212% +$112K 0.01% 675
2021
Q3 		$61.9K Hold
3,780
– – ﹤0.01% 811
2021
Q2 		$63.6K Hold
3,780
– – ﹤0.01% 802
2021
Q1 		$69K Hold
3,780
– – ﹤0.01% 749
2020
Q4 		$68.8K Buy
+3,780
New +$66.3K ﹤0.01% 734

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Leonteq Securities AG's TAK Position: Q4 2022 in Review

Leonteq Securities AG sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 8,000 shares — an estimated $104K sold.

Leonteq Securities AG first reported a position in TAK in Q4 2020 and held it in 8 quarters. The position peaked at $161K in Q4 2021. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • Leonteq Securities AG reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Leonteq Securities AG sold 8,000 Takeda Pharmaceutical shares in Q4 2022, an estimated $104K.
  • Leonteq Securities AG first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 8 quarters.
  • Leonteq Securities AG's Takeda Pharmaceutical position peaked at $161K in Q4 2021.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on Leonteq Securities AG's 13F filing for Q4 2022, filed 26 Mar 2026.